Action Point Financial Planning’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-90
Closed -$1.52K – 519
2026
Q2
$1.52K Buy
+90
New +$1.23K ﹤0.01% 2352

Other funds holding AMRX

Action Point Financial Planning's AMRX Position: Q3 2026 in Review

Action Point Financial Planning sold out of Amneal Pharmaceuticals (AMRX) in Q3 2026, closing a stake of 90 shares — an estimated $1.52K sold.

Action Point Financial Planning first reported a position in AMRX in Q2 2026 and held it in 1 quarter. The position peaked at $1.52K in Q2 2026. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Action Point Financial Planning reported no remaining Amneal Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 90 Amneal Pharmaceuticals shares in Q3 2026, an estimated $1.52K.
  • Action Point Financial Planning first reported a position in Amneal Pharmaceuticals in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's Amneal Pharmaceuticals position peaked at $1.52K in Q2 2026.
  • 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.